Peplin News
Most Popular Peplin Story
Peplin gains $24M to fund Phase III
Australian transplant Peplin has rounded up $24 million and two new top executives. New Enterprise Associates, MPM Capital, and two Australian investors put up the money. Peplin relocated to... Read more...
Latest Headlines
- September 2, 2008
- June 10, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
